Pineridge Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$4.04K Sell
54
-15
-22% -$1.03K ﹤0.01% 296
2025
Q2
$4.77K Buy
69
+1
+1% +$66 ﹤0.01% 308
2025
Q1
$4.63K Sell
68
-81
-54% -$4.85K ﹤0.01% 316
2024
Q4
$6.67K Buy
149
+100
+204% +$5.61K ﹤0.01% 344
2024
Q3
$3.06K Sell
49
-57
-54% -$3.33K ﹤0.01% 413
2024
Q2
$6.27K Hold
106
﹤0.01% 343
2024
Q1
$8.42K Sell
106
-156
-60% -$11.9K ﹤0.01% 317
2023
Q4
$20.7K Buy
+262
New +$18.6K 0.01% 265

Other funds holding CVS

Pineridge Advisors's CVS Position: Q3 2025 in Review

Pineridge Advisors reduced its CVS Health (CVS) stake by 22% in Q3 2025, selling an estimated $1.03K and leaving 54 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #296.

Pineridge Advisors first reported a position in CVS in Q4 2023 and has held it in 8 quarters since. The position peaked at $20.7K in Q4 2023. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Pineridge Advisors held 54 shares of CVS Health worth $4.04K as of Q3 2025.
  • Pineridge Advisors sold 15 CVS Health shares in Q3 2025, an estimated $1.03K.
  • CVS Health made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #296 holding.
  • Pineridge Advisors first reported a position in CVS Health in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's CVS Health position peaked at $20.7K in Q4 2023.
  • 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.